ALK-Abelló A/S
ALK-B
Classement en actions
#2433
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Prix de l'action
$36.23
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$8.04B
Changement (1 jour)
-1.72%
Changement (1 an)
12.00%
Pays
DK
Échange ALK-Abelló A/S (ALK-B)
Catégorie
Healthcare
Capitalisation boursière de ALK-Abelló A/S(ALK-B)
Capitalisation boursière: $8.04B
En October 2026, ALK-Abelló A/S a une capitalisation boursière de $8.04B. Cela fait de ALK-Abelló A/S la 2433rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de ALK-Abelló A/S du 2009 au 2026
ALK-B par rapport au top 5 des plus populaires stocks
